Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

PROCEPT BioRobotics Corporation (PRCT) had Revenue of $69.16M for the most recently reported fiscal quarter, ending 2025-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-03-31

Income Statement Financials
Revenue	$69.16M
Net Income	$-24.74M
Cost of Goods Sold	$25.00M
Gross Profit	$44.16M
Operating Expenses	$96.60M
Operating Income	$-27.44M
Non-Operating Income/Expense	$2.70M
Pre-Tax Income	$-24.74M
Normalized Pre-Tax Income	$-24.74M
Income after Taxes	$-24.74M
Income from Continuous Operations	$-24.74M
Consolidated Net Income/Loss	$-24.74M
Normalized Income after Taxes	$-24.74M
EBIT	$-27.44M
EBITDA	$-25.96M
Weighted-Average Shares Outstanding (Basic)	54.92M
Weighted-Average Shares Outstanding (Diluted)	54.92M
Earnings per Share (EPS) (Basic)	$-0.45
Earnings per Share (EPS) (Diluted)	$-0.45
Balance Sheet Financials
Current Assets	$465.79M
Property, Plant, and Equipment	$28.13M
Long-Term Assets	$53.58M
Total Assets	$519.38M
Current Liabilities	$52.06M
Long-Term Debt	$51.50M
Long-Term Liabilities	$78.15M
Total Liabilities	$130.22M
Common Equity	$389.16M
Tangible Shareholders Equity	$388.29M
Shareholders Equity	$389.16M
Common Shares Outstanding	55.28M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-16.98M
Cash Flow from Investing Activities	$-1.84M
Cash Flow from Financial Activities	$1.30M
Beginning Cash	$336.76M
End Cash	$319.25M
Increase/Decrease in Cash	$-17.52M
Stock-Based Compensation	$10.11M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	8.95
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.12
Debt to Equity Ratio	0.14
Gross Margin	63.85%
Operating Margin	-39.67%
EBIT Margin	-39.67%
EBITDA Margin	--
Pre-Tax Profit Margin	-35.77%
Profit Margin	-35.77%
Free Cash Flow	$-18.82M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.13
Inventory Turnover	0.40
Receiveable Turnover	0.87
Days Sales in Receivables	103.15
Return on Equity	-6.36%
Return on Tangible Equity	-6.37%
Return on Assets	-4.76%
Return on Investments	-5.61%
Book Value Per Share	$7.04
Free Cash Flow per Share	$-0.34
Operating Cash Flow per Share	$-0.31

Data from Zacks Investment Research, Inc.